Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Traws Pharma, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −1 vs. Q1 2023
- Shares held
- 1.86M
- +429.9K (+30.1%) vs. Q1 2023
- Total value
- $2.19M
- +$1.15M (+110.1%) vs. Q1 2023
- New holders
- 4
- 7 more added
- Sold out
- 5
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $5.19M |
| Q1 2026 | 28 | $6.62M |
| Q4 2025 | 22 | $3.86M |
| Q3 2025 | 18 | $2.41M |
| Q2 2025 | 19 | $1.87M |
| Q1 2025 | 19 | $3.98M |
| Q4 2024 | 19 | $10.2M |
| Q3 2024 | 12 | $3.80M |
| Q2 2024 | 30 | $1.36M |
| Q1 2024 | 26 | $1.88M |
| Q4 2023 | 27 | $1.35M |
| Q3 2023 | 28 | $1.27M |
| Q2 2023 | 24 | $2.19M |
| Q1 2023 | 25 | $1.04M |
| Q4 2022 | 29 | $1.01M |
| Q3 2022 | 30 | $1.54M |
| Q2 2022 | 32 | $2.36M |
| Q1 2022 | 28 | $3.60M |
| Q4 2021 | 34 | $6.14M |
| Q3 2021 | 37 | $10.5M |
| Q2 2021 | 24 | $10.9M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Traws Pharma, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 708,618 | $836.2K | 0.00% | +85,314+13.7% | Added |
| BlackRock Inc. | 248,881 | $293.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 234,674 | $277.0K | 0.00% | +89,880+62.1% | Added |
| Geode Capital Management, LLC | 169,501 | $200.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 157,798 | $186.2K | 0.00% | +157,798 | New |
| Two Sigma Advisers, LP | 143,339 | $169.1K | 0.00% | +116,600+436.1% | Added |
| State Street Corp | 52,790 | $62.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 30,783 | $36.3K | 0.00% | 00.0% | Unchanged |
| Beacon Pointe Advisors, LLC | 28,417 | $33.5K | 0.00% | +15,286+116.4% | Added |
| Morgan Stanley | 20,110 | $23.7K | 0.00% | +9,248+85.1% | Added |
| Hillcrest Wealth Advisors - NY, LLC | 16,723 | $19.7K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 12,717 | $15.0K | 0.00% | +12,717 | New |
| Mutual Advisors, LLC | 12,700 | $15.0K | 0.00% | +12,700 | New |
| Edmond de Rothschild Holding S.A. | 6,666 | $7.87K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,655 | $6.67K | 0.00% | −8,940−61.3% | Reduced |
| Tower Research Capital LLC (TRC) | 3,548 | $4.19K | 0.00% | −1,697−32.4% | Reduced |
| Group One Trading, L.P. | 1,613 | $1.90K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,004 | $1.19K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 400 | $472 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 151 | $178 | 0.00% | +6+4.1% | Added |
| Bank of America Corp | 33 | $39 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 33 | $39 | 0.00% | +33 | New |
| FMR LLC | 3 | $4 | 0.00% | +2+200.0% | Added |
| Royal Bank of Canada | 46 | $0 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −28,395−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,229−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,308−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −46−100.0% | Sold out |